Good Day BIO Newsletter

A busy week in Washington, D.C., brought legislation to fix the Inflation Reduction Act “pill penalty,” bipartisan calls for PBM reform, and BIO CEO John F. Crowley explaining why Congress needs to act to support rare disease drug development. (1012 words, 5 minutes, 3 seconds)

We’re getting ready for Rare Disease Day (February 28) with a look at how policy can support patients and how BIO is engaging with the FDA. (960 words, 4 minutes, 48 seconds)

ICYMI: PBM legislation was reintroduced in the Senate. We have details, plus more on the biotech market outlook, the importance of Accelerated Approval, and what a new shrimp vaccine tells us about innate immunity. (718 words, 3 minutes, 35 seconds)

We recap Day 2 of the 2025 BIO CEO and Investor Conference in New York with a look at what we can expect from the new administration and Congress, as well as promising schizophrenia developments. (347 words, 1 minute, 44 seconds)

We recap Day 1 of the 2025 BIO CEO and Investor Conference in New York with exciting developments on obesity drugs and AI. (203 words, 1 minute, 0 seconds)

We're at the BIO CEO & Investor Conference in New York – follow our exclusive coverage at Bio.News and on social media with #BIOCEO25. Below, we have the news you need to know today, plus a look back at why Vertex's recent approval matters in the war on opioids. (701 words, 3 minutes, 35 seconds)

We're back on a Thursday with news about the ORPHAN Cures Act. (2 minutes, 17 seconds. Contains 459 words)

BIO reacts to plans for tariffs on Canada, Mexico, and China—plus, BIO explains how the new administration can use biotech to help farmers. (671 words, 3 minutes, 21 seconds)  

This week, we unpack BIO’s priorities for the 119th Congress and take a deep dive into recently reintroduced legislation that would support the development of sustainable aviation fuel. (730 words, 3 minutes, 39 seconds)

As the new Trump administration begins in freezing-cold Washington, we look at the FTC’s new report on PBMs, what to know about Medicare Part D changes, what happened at JPM Week, and much more. (862 words, 4 minutes, 18 seconds)